A prospective patient observational study of the role of hyperhomocysteinemia in restenosis in patients undergoing infrainguinal angioplasty or bypass procedures

International Angiology

Volumn 25, Issue 4, 2006, Pages 378-384

  Hansrani, M ^a   Oates, C ^a   Stansby, Gerard ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Hyperhomocysteinemia; Ischemia; Limb; Percutaneous transluminal angioplasty

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BYPASS SURGERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLIC ACID BLOOD LEVEL; GRAFT OCCLUSION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; LIMB ISCHEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; OBSERVATIONAL STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANASTOMOSIS, SURGICAL; ANGIOPLASTY; ATHEROSCLEROSIS; FEMALE; GROIN; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE;

EID: 33847615569     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Taylor LM Jr, DeFrang RD, Harris EJ Jr, Porter JM. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg 1991;13:128-36.
2. Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-205; discussion 205-6.
3. Whittemore AD, Clowes AW, Couch NP, Mannick JA. Secondary femoropopliteal reconstruction. Ann Surg 1981;193:35-42.
4. Szilagyi DE, Elliott JP, Hageman JH, Smith RF, Dall'olmo CA. Biological fate of autogenous vein implants as arterial substitutes. Ann Surg 1973;178:232-44.
5. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983;49:208-15.
6. Fuchs JC, Mitchener JSd, Hagen PO. Postoperative changes in autologous vein grafts. Ann Surg 1978;188: 1-15.
7. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-28.
8. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
9. Berwanger CS, Jeremy JY, Stansby G. Homocysteine and vascular disease. Br J Surg 1995;82:726-31.
10. Van den Berg M, Boers G. Homosycteinuria: what about mild hyperhomocysteinaemia? Postgrad Med J 1996;72: 513-8.
11. Hansrani M, Gillespie J, Stansby G. Homocysteine in myointimal hyperplasia. Eur J Vasc Endovasc Surg 2002;23:3-10.
12. Southern FN, Cruz N, Fink LM, Cooney CA, Barone GW, Eidt JF et al. Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model. J Vasc Surg 1998;28:909-18.
13. Irvine C, Wilson YG, Currie IC, McGrath C, Scott J, Day A et al. Hyperhomocysteinaemia is a risk factor for vein graft stenosis. Eur J Vasc Endovasc Surg 1996;12:304-9.
14. Strangeways T, Fell HB. Experimental studies on the differentiation of embryonic tissues growing in vivo and in vitro. Proc R Soc London 1926;99:340-66.
15. Schneede J, Refsum, H, Ueland, PM. Biological and environmental determinants of plasma homocysteine. Semin Thromb Hemost 2000;26:263-79.
16. Scoenfeld N, O'Donell TF, Bush, HL. The management of early in situ saphenous vein bypass occlusion. Arch Surg 1987;122:871-5.
17. Rutherford R, Baker D, Ernst C, Johnston KW, Porter JM, Alan S et al. Recommended standards for reports dealing with lower extremity ischaemia: revised version. J Vasc Surg 1997;26:517-38.
18. Mireskandari M, Schachter M, Timms IGO, Sever P, Wolfe JHN. Plasma homocysteine is an independant risk factor for vein graft stenosis. Br J Surg 1998;85 Suppl 1:27.
19. Beattie DK, Sian M, Greenhalgh RM, Davies AH. Influence of systemic factors on pre-existing intimal hyperplasia and their effect on the outcome of infrainguinal arterial reconstruction with vein. Br J Surg 1999;86: 1441-7.
20. Tsakiris DA, Tschopl M, Jager K, Haefeli WE, Wolf F, Marbet GA. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999;142:193-200.
21. Currie IC, Wilson YG, Scott J, Day A, Stansbie B, Baird RN et al. Homocysteine: an independant risk factor for the failure of vascular intervention. Br J Surg 1996;83: 1238-41.
22. Taylor LM Jr, Moneta GL, Sexton GJ, Schuff RA, Porter JM. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 1999;29:8-19; discussion 19-21.
23. Albach A, Roth, WD, Edgren, J, Lepantalo, M. Interobserver agreement in duplex scanning for vein grafts. Eur J Vasc Endovasc Surg 2004;19:504-8.
24. Leng G, Fowkes FGR. The epidemiology of peripheral arterial disease. Vasc Med Rev 1993;4:5-18.
25. Ahn S, Rutherford RB, Becker GJ, Comerota AJ, Johnston W, McClean GK et al. Reporting standards for lower extremity arterial endovascular procedures. J Vasc Surg 1993;17:1103-7.
26. Leng G, Fowkes FGR. Epidemiology and risk factors for peripheral arterial disease. In: Beard J, Gaines, PA, editor. Vascular and endovascular surgery. London: Harcourt Publishers Ltd; 2001.p.1-26.